Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 39

1.

Interrelational changes in the epidemiology and clinical features of nontuberculous mycobacterial pulmonary disease and tuberculosis in a referral hospital in Japan.

Furuuchi K, Morimoto K, Yoshiyama T, Tanaka Y, Fujiwara K, Okumura M, Izumi K, Shiraishi Y, Mitarai S, Ogata H, Kurashima A, Yoshimori K, Ohta K, Goto H, Sasaki Y.

Respir Med. 2019 Jun;152:74-80. doi: 10.1016/j.rmed.2019.05.001. Epub 2019 May 8.

PMID:
31128614
2.

Mycobacterium avium Complex Pleuritis with Elevated Anti-glycopeptidolipid-core IgA Antibody Levels in Pleural Effusion.

Furuuchi K, Morimoto K, Fujiwara K, Tanaka Y, Takemura T, Kurashima A, Yoshimori K, Ohta K, Sasaki Y.

Intern Med. 2019 May 22. doi: 10.2169/internalmedicine.2751-19. [Epub ahead of print]

3.

MORAb-202, an Antibody-Drug Conjugate Utilizing Humanized Anti-human FRα Farletuzumab and the Microtubule-targeting Agent Eribulin, has Potent Antitumor Activity.

Cheng X, Li J, Tanaka K, Majumder U, Milinichik AZ, Verdi AC, Maddage CJ, Rybinski KA, Fernando S, Fernando D, Kuc M, Furuuchi K, Fang F, Uenaka T, Grasso L, Albone EF.

Mol Cancer Ther. 2018 Dec;17(12):2665-2675. doi: 10.1158/1535-7163.MCT-17-1215. Epub 2018 Sep 27.

PMID:
30262588
4.

Risk stratification for the development of chronic pulmonary aspergillosis in patients with Mycobacterium avium complex lung disease.

Furuuchi K, Ito A, Hashimoto T, Kumagai S, Ishida T.

J Infect Chemother. 2018 Aug;24(8):654-659. doi: 10.1016/j.jiac.2018.04.002. Epub 2018 Apr 26.

PMID:
29705392
5.

Clinical significance of Aspergillus species isolated from respiratory specimens in patients with Mycobacterium avium complex lung disease.

Furuuchi K, Ito A, Hashimoto T, Kumagai S, Ishida T.

Eur J Clin Microbiol Infect Dis. 2018 Jan;37(1):91-98. doi: 10.1007/s10096-017-3105-6. Epub 2017 Sep 17.

PMID:
28920166
6.

Development and validation of a prognostic scoring model for Mycobacterium avium complex lung disease: an observational cohort study.

Kumagai S, Ito A, Hashimoto T, Marumo S, Tokumasu H, Kotani A, Yamaki H, Shirata M, Furuuchi K, Fukui M, Ishida T.

BMC Infect Dis. 2017 Jun 19;17(1):436. doi: 10.1186/s12879-017-2544-0.

7.

Reenlargement of radiation necrosis after stereotactic radiotherapy for brain metastasis from lung cancer during bevacizumab treatment.

Furuuchi K, Nishiyama A, Yoshioka H, Yokoyama T, Ishida T.

Respir Investig. 2017 Mar;55(2):184-187. doi: 10.1016/j.resinv.2016.11.001. Epub 2016 Dec 6.

PMID:
28274537
8.

Clinical significance of the radiological severity score in Mycobacterium avium complex lung disease patients.

Furuuchi K, Ito A, Hashimoto T, Kumagai S, Ishida T.

Int J Tuberc Lung Dis. 2017 Apr 1;21(4):452-457. doi: 10.5588/ijtld.16.0711. Epub 2017 Jan 26.

PMID:
28150579
9.

Targeting endosialin/CD248 through antibody-mediated internalization results in impaired pericyte maturation and dysfunctional tumor microvasculature.

Rybinski K, Imtiyaz HZ, Mittica B, Drozdowski B, Fulmer J, Furuuchi K, Fernando S, Henry M, Chao Q, Kline B, Albone E, Wustner J, Lin J, Nicolaides NC, Grasso L, Zhou Y.

Oncotarget. 2015 Sep 22;6(28):25429-40. doi: 10.18632/oncotarget.4559.

10.

Structural basis for ligand-mediated mouse GITR activation.

Zhou Z, Tone Y, Song X, Furuuchi K, Lear JD, Waldmann H, Tone M, Greene MI, Murali R.

Proc Natl Acad Sci U S A. 2008 Jan 15;105(2):641-5. doi: 10.1073/pnas.0711206105. Epub 2008 Jan 4.

11.

Smad3 and NFAT cooperate to induce Foxp3 expression through its enhancer.

Tone Y, Furuuchi K, Kojima Y, Tykocinski ML, Greene MI, Tone M.

Nat Immunol. 2008 Feb;9(2):194-202. Epub 2007 Dec 23.

PMID:
18157133
12.

OX40 gene expression is up-regulated by chromatin remodeling in its promoter region containing Sp1/Sp3, YY1, and NF-kappa B binding sites.

Tone Y, Kojima Y, Furuuchi K, Brady M, Yashiro-Ohtani Y, Tykocinski ML, Tone M.

J Immunol. 2007 Aug 1;179(3):1760-7.

13.
14.

HOXD3-overexpression increases integrin alpha v beta 3 expression and deprives E-cadherin while it enhances cell motility in A549 cells.

Ohta H, Hamada J, Tada M, Aoyama T, Furuuchi K, Takahashi Y, Totsuka Y, Moriuchi T.

Clin Exp Metastasis. 2006;23(7-8):381-90. Epub 2006 Dec 23.

15.

FOXP3 ensembles in T-cell regulation.

Li B, Samanta A, Song X, Furuuchi K, Iacono KT, Kennedy S, Katsumata M, Saouaf SJ, Greene MI.

Immunol Rev. 2006 Aug;212:99-113. Review.

PMID:
16903909
16.

Centrosomal proteins Nde1 and Su48 form a complex regulated by phosphorylation.

Hirohashi Y, Wang Q, Liu Q, Li B, Du X, Zhang H, Furuuchi K, Masuda K, Sato N, Greene MI.

Oncogene. 2006 Oct 5;25(45):6048-55. Epub 2006 May 8.

PMID:
16682949
17.

Epigenetic silencing of E- and P-cadherin gene expression in human melanoma cell lines.

Tsutsumida A, Hamada J, Tada M, Aoyama T, Furuuchi K, Kawai Y, Yamamoto Y, Sugihara T, Moriuchi T.

Int J Oncol. 2004 Nov;25(5):1415-21.

PMID:
15492833
18.

The centrosome in normal and transformed cells.

Wang Q, Hirohashi Y, Furuuchi K, Zhao H, Liu Q, Zhang H, Murali R, Berezov A, Du X, Li B, Greene MI.

DNA Cell Biol. 2004 Aug;23(8):475-89. Review.

PMID:
15307950
19.

Expression of AIE-75 PDZ-domain protein induces G2/M cell cycle arrest in human colorectal adenocarcinoma SW480 cells.

Hirai A, Tada M, Furuuchi K, Ishikawa S, Makiyama K, Hamada J, Okada F, Kobayashi I, Fukuda H, Moriuchi T.

Cancer Lett. 2004 Aug 10;211(2):209-18.

PMID:
15219944
20.

Nuclear accumulation of beta-catenin without an additional somatic mutation in coding region of the APC gene in hepatoblastoma from a familial adenomatous polyposis patient.

Inukai T, Furuuchi K, Sugita K, Uno K, Ooi A, Sasaki F, Hamada J, Moriuchi T, Nakazawa S.

Oncol Rep. 2004 Jan;11(1):121-6. Review.

PMID:
14654913
21.

Reconstructed beta-catenin/TCF4 signaling in yeast applicable to functional evaluation of APC mutations.

Yamada H, Furuuchi K, Aoyama T, Kataoka A, Hamada J, Tada M, Okushiba S, Kondo S, Moriuchi T, Katoh H.

Am J Pathol. 2003 Dec;163(6):2201-9.

22.

Role of extracellular subdomains of p185c-neu and the epidermal growth factor receptor in ligand-independent association and transactivation.

Kumagai T, Katsumata M, Hasegawa A, Furuuchi K, Funakoshi T, Kawase I, Greene MI.

Proc Natl Acad Sci U S A. 2003 Aug 5;100(16):9220-5. Epub 2003 Jul 16.

23.

Transduction of HOXD3-antisense into human melanoma cells results in decreased invasive and motile activities.

Okubo Y, Hamada J, Takahashi Y, Tada M, Tsutsumida A, Furuuchi K, Aoyama T, Sugihara T, Moriuchi T.

Clin Exp Metastasis. 2002;19(6):503-11.

PMID:
12405287
24.

Increased expression of beta-catenin predicts better prognosis in nonsmall cell lung carcinomas.

Hommura F, Furuuchi K, Yamazaki K, Ogura S, Kinoshita I, Shimizu M, Moriuchi T, Katoh H, Nishimura M, Dosaka-Akita H.

Cancer. 2002 Feb 1;94(3):752-8.

25.

HOXD3 enhances motility and invasiveness through the TGF-beta-dependent and -independent pathways in A549 cells.

Miyazaki YJ, Hamada J, Tada M, Furuuchi K, Takahashi Y, Kondo S, Katoh H, Moriuchi T.

Oncogene. 2002 Jan 24;21(5):798-808.

26.

Development of a yeast stop codon assay readily and generally applicable to human genes.

Kataoka A, Tada M, Yano M, Furuuchi K, Cornain S, Hamada J, Suzuki G, Yamada H, Todo S, Moriuchi T.

Am J Pathol. 2001 Oct;159(4):1239-45.

27.

Overexpression of homeobox gene HOXD3 induces coordinate expression of metastasis-related genes in human lung cancer cells.

Hamada Ji, Omatsu T, Okada F, Furuuchi K, Okubo Y, Takahashi Y, Tada M, Miyazaki YJ, Taniguchi Y, Shirato H, Miyasaka K, Moriuchi T.

Int J Cancer. 2001 Aug 15;93(4):516-25.

28.

Interaction of MCC2, a novel homologue of MCC tumor suppressor, with PDZ-domain Protein AIE-75.

Ishikawa S, Kobayashi I, Hamada J, Tada M, Hirai A, Furuuchi K, Takahashi Y, Ba Y, Moriuchi T.

Gene. 2001 Apr 4;267(1):101-10.

PMID:
11311560
29.

Frequent deletions and mutations of the beta-catenin gene are associated with overexpression of cyclin D1 and fibronectin and poorly differentiated histology in childhood hepatoblastoma.

Takayasu H, Horie H, Hiyama E, Matsunaga T, Hayashi Y, Watanabe Y, Suita S, Kaneko M, Sasaki F, Hashizume K, Ozaki T, Furuuchi K, Tada M, Ohnuma N, Nakagawara A.

Clin Cancer Res. 2001 Apr;7(4):901-8.

30.

Inactivate the remaining p53 allele or the alternate p73? Preferential selection of the Arg72 polymorphism in cancers with recessive p53 mutants but not transdominant mutants.

Tada M, Furuuchi K, Kaneda M, Matsumoto J, Takahashi M, Hirai A, Mitsumoto Y, Iggo RD, Moriuchi T.

Carcinogenesis. 2001 Mar;22(3):515-7.

PMID:
11238194
31.

[Development of a detection system (APC yeast color assay) of APC mutations by color change of yeast].

Furuuchi K.

Hokkaido Igaku Zasshi. 2000 Nov;75(6):385-97. Japanese.

PMID:
11193931
32.

Somatic mutations of the APC gene in primary breast cancers.

Furuuchi K, Tada M, Yamada H, Kataoka A, Furuuchi N, Hamada J, Takahashi M, Todo S, Moriuchi T.

Am J Pathol. 2000 Jun;156(6):1997-2005.

33.

Distinct prognostic values of p53 mutations and loss of estrogen receptor and their cumulative effect in primary breast cancers.

Takahashi M, Tonoki H, Tada M, Kashiwazaki H, Furuuchi K, Hamada J, Fujioka Y, Sato Y, Takahashi H, Todo S, Sakuragi N, Moriuchi T.

Int J Cancer. 2000 Jan 20;89(1):92-9.

34.

A functional and quantitative mutational analysis of p53 mutations in yeast indicates strand biases and different roles of mutations in DMBA- and BBN-induced tumors in rats

Yamamoto K, Nakata D, Tada M, Tonoki H, Nishida T, Hirai A, Ba Y, Aoyama T, Hamada J, Furuuchi K, Harada H, Hirai K, Shibahara N, Katsuoka Y, Moriuchi T.

Int J Cancer. 2000 Mar 15;85(6):898. No abstract available.

35.

A functional and quantitative mutational analysis of p53 mutations in yeast indicates strand biases and different roles of mutations in DMBA- and BBN-induced tumors in rats.

Yamamoto K, Nakata D, Tada M, Tonoki H, Nishida T, Hirai A, Ba Y, Aoyama T, Hamada J, Furuuchi K, Harada H, Hirai K, Shibahara N, Katsuoka Y, Moriuchi T.

Int J Cancer. 1999 Nov 26;83(5):700-5. Erratum in: Int J Cancer 2000 Mar 15;85(6):898.

36.

A novel A-kinase anchoring protein in the heart interacts with G alpha 13.

Suzuki M, Furuuchi K, Tonoki H, Ozaki T, Iizuka K, Murakami T, Kitabatake A, Kawaguchi H.

Jpn Heart J. 1999 Mar;40(2):199-208.

37.

Glial cell line-derived neurotrophic factor induces barrier function of endothelial cells forming the blood-brain barrier.

Igarashi Y, Utsumi H, Chiba H, Yamada-Sasamori Y, Tobioka H, Kamimura Y, Furuuchi K, Kokai Y, Nakagawa T, Mori M, Sawada N.

Biochem Biophys Res Commun. 1999 Jul 22;261(1):108-12.

PMID:
10405331
38.

Suppression of pancreatic cancer by the dominant negative ras mutant, N116Y.

Shichinohe T, Senmaru N, Furuuchi K, Ogiso Y, Ishikura H, Yoshiki T, Takahashi T, Kato H, Kuzumaki N.

J Surg Res. 1996 Dec;66(2):125-30.

PMID:
9024823
39.

Gelsolin: a candidate for suppressor of human bladder cancer.

Tanaka M, Müllauer L, Ogiso Y, Fujita H, Moriya S, Furuuchi K, Harabayashi T, Shinohara N, Koyanagi T, Kuzumaki N.

Cancer Res. 1995 Aug 1;55(15):3228-32.

Supplemental Content

Loading ...
Support Center